| EGFR | EGFR | TK | 4lrm | B | | n-{4-[(3-bromophenyl)amino]quinazolin-6-yl}propanamide | Human | 867 | 0.40 | |
| EGFR | EGFR | TK | 4ll0 | A | | n-{4-[(3-bromophenyl)amino]quinazolin-6-yl}propanamide | Human | 804 | 0.40 | |
| AURKA (AurA) | Aur | Other | 2c6e | A | | n-{5-[(7-{[(2s)-2-hydroxy-3-piperidin-1-ylpropyl]oxy}-6-methoxyquinazolin-4-yl)amino]pyrimidin-2-yl}benzamide | Human | 1989 | 0.41 | |
| EGFR | EGFR | TK | 4hjo | A | | [6,7-bis(2-methoxy-ethoxy)quinazoline-4-yl]-(3-ethynylphenyl)amine | Human | 835 | 0.69 | |
| EGFR | EGFR | TK | 4ll0 | B | | n-{4-[(3-bromophenyl)amino]quinazolin-6-yl}propanamide | Human | 796 | 0.40 | |
| EGFR | EGFR | TK | 3ug2 | A | A | gefitinib | Human | 898 | 0.44 | |
| GAK | NAK | Other | 5y80 | A | A | gefitinib | Human | 10329 | 0.44 | |
| GAK | NAK | Other | 5y7z | A | | gefitinib | Human | 10332 | 0.44 | |
| CDK2 | CDK | CMGC | 1di8 | A | | 4-[3-hydroxyanilino]-6,7-dimethoxyquinazoline | Human | 4577 | 0.53 | |
| GAK | NAK | Other | 5y7z | B | | gefitinib | Human | 10331 | 0.44 | |
| CSNK2A1 (CK2a1) | CK2 | CMGC | 3pe2 | A | B | 5-[(3-ethynylphenyl)amino]pyrimido[4,5-c]quinoline-8-carboxylic acid | Human | 5519 | 0.40 | |
| CSNK2A1 (CK2a1) | CK2 | CMGC | 3pe2 | A | A | 5-[(3-ethynylphenyl)amino]pyrimido[4,5-c]quinoline-8-carboxylic acid | Human | 5508 | 0.40 | |
| EGFR | EGFR | TK | 4lrm | E | | n-{4-[(3-bromophenyl)amino]quinazolin-6-yl}propanamide | Human | 825 | 0.40 | |
| EGFR | EGFR | TK | 3ug2 | A | B | gefitinib | Human | 819 | 0.44 | |
| EGFR | EGFR | TK | 2ito | A | | gefitinib | Human | 783 | 0.44 | |
| EGFR | EGFR | TK | 2itz | A | | gefitinib | Human | 789 | 0.44 | |
| AURKA (AurA) | Aur | Other | 2c6e | B | | n-{5-[(7-{[(2s)-2-hydroxy-3-piperidin-1-ylpropyl]oxy}-6-methoxyquinazolin-4-yl)amino]pyrimidin-2-yl}benzamide | Human | 2046 | 0.41 | |
| EGFR | EGFR | TK | 1m17 | A | A | [6,7-bis(2-methoxy-ethoxy)quinazoline-4-yl]-(3-ethynylphenyl)amine | Human | 873 | 0.69 | |
| GAK | NAK | Other | 5y80 | A | B | gefitinib | Human | 10330 | 0.44 | |
| EPHB4 (EphB4) | Eph | TK | 2vwu | A | | n-(5-chloro-1,3-benzodioxol-4-yl)-6-methoxy-7-(3-piperidin-1-ylpropoxy)quinazolin-4-amine | Human | 370 | 0.41 | |
| ABL1 | Abl | TK | 8ssn | A | | 6,7-dimethoxy-n-(4-phenoxyphenyl)quinazolin-4-amine | Human | 14878 | 0.44 | |
| MAPK14 (p38a) | MAPK | CMGC | 1di9 | A | | 4-[3-methylsulfanylanilino]-6,7-dimethoxyquinazoline | Human | 5251 | 0.48 | |
| TTBK1 | TTBK | CK1 | 4btk | A | | 4-[3-hydroxyanilino]-6,7-dimethoxyquinazoline | Human | 771 | 0.53 | |
| EGFR | EGFR | TK | 4i22 | A | | gefitinib | Human | 823 | 0.44 | |
| EGFR | EGFR | TK | 4lrm | D | | n-{4-[(3-bromophenyl)amino]quinazolin-6-yl}propanamide | Human | 786 | 0.40 | |
| EGFR | EGFR | TK | 4wkq | A | A | gefitinib | Human | 889 | 0.44 | |
| EGFR | EGFR | TK | 4lrm | A | | n-{4-[(3-bromophenyl)amino]quinazolin-6-yl}propanamide | Human | 901 | 0.40 | |
| EGFR | EGFR | TK | 4wkq | A | B | gefitinib | Human | 837 | 0.44 | |
| EGFR | EGFR | TK | 4lrm | C | | n-{4-[(3-bromophenyl)amino]quinazolin-6-yl}propanamide | Human | 781 | 0.40 | |
| EGFR | EGFR | TK | 1m17 | A | B | [6,7-bis(2-methoxy-ethoxy)quinazoline-4-yl]-(3-ethynylphenyl)amine | Human | 905 | 0.69 | |
| EGFR | EGFR | TK | 2ity | A | | gefitinib | Human | 790 | 0.44 | |
| TTBK2 | TTBK | CK1 | 6u0k | B | A | 4-[3-hydroxyanilino]-6,7-dimethoxyquinazoline | Human | 12049 | 0.53 | |
| TTBK2 | TTBK | CK1 | 6u0k | A | A | 4-[3-hydroxyanilino]-6,7-dimethoxyquinazoline | Human | 12046 | 0.53 | |
| TTBK2 | TTBK | CK1 | 6u0k | B | B | 4-[3-hydroxyanilino]-6,7-dimethoxyquinazoline | Human | 12047 | 0.53 | |
| TTBK2 | TTBK | CK1 | 6u0k | A | B | 4-[3-hydroxyanilino]-6,7-dimethoxyquinazoline | Human | 12048 | 0.53 | |
| RET | Ret | TK | 5amn | A | | 4-[3-hydroxyanilino]-6,7-dimethoxyquinazoline | Human | 6412 | 0.53 | |